A Study of Evacetrapib in Participants With Abnormal Cholesterol
Clinical trial NCT02168803 · COMPLETED
Trial details
- NCT number
- NCT02168803
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-12-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.